ANTI-TOPOISOMERASE POSITIVE SYSTEMIC SCLEROSIS PROGNOSIS INFAUST?

被引：0
|
作者：
Boonstra, M. [1 ]
Beerends, G. A. [1 ]
Scherer, H. U. [1 ]
de Vries-Bouwstra, J. K. [1 ]
机构：
[1] LUMC, Rheumatol, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.6414
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0650
引用
收藏
页码：1279 / 1280
页数：2
相关论文
共 50 条
  • [21] Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort
    Ciaffi, J.
    van Leeuwen, N. M.
    Huizinga, T. W. J.
    de Vries-Bouwstra, J. K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : S25 - S28
  • [22] Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
    Ochoa, E.
    Martin, J. -E.
    Assassi, S.
    Beretta, L.
    Carreira, P.
    Guillen, A.
    Simeon, C. P.
    Koumakis, E.
    Dieude, P.
    Allanore, Y.
    Garcia-Hernandez, F. J.
    Espinosa, G.
    Castellvi, I.
    Trapiella, J. L.
    Rodriguez, L.
    Gonzalez-Gay, M. A.
    Egurbide, M. V.
    Saez, L.
    Callejas-Rubio, J. L.
    Vargas-Hitos, J. A.
    Hunzelmann, N.
    Riemekasten, G.
    Witte, T.
    Distler, J. H. W.
    Kreuter, A.
    Lunardi, C.
    Santaniello, A.
    Tan, F. K.
    Shiels, P. G.
    Herrick, A.
    Worthington, J.
    Vonk, M. C.
    Koeleman, B. P.
    Radstake, T. R. D. J.
    Mayes, M. D.
    Martin, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : S31 - S35
  • [23] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Fritzler, Marvin
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
  • [24] Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study
    Magnant, J.
    Ohresser, M.
    Allanore, Y.
    de Monte, M.
    Lafosse-Marin, M.
    Degenne, D.
    Guilmot, J. L.
    Watier, H.
    Diot, E.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 2203 - 2207
  • [25] Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Hasegawa, Minoru
    Matsushita, Takashi
    Takehara, Kazuhiko
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 142 - 144
  • [26] Levels of anti-topoisomerase I antibodies by ELISA correlate with disease severity in systemic sclerosis.
    Sato, S
    Hamaguchi, Y
    Hasegawa, M
    Takehara, K
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S326 - S326
  • [27] The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature
    Hoekstra, E. M.
    Liem, S. I. E.
    Boonstra, M.
    Fehres, C. M.
    Schoones, J. W.
    Huizinga, T. W. J.
    de Vries-Bouwstra, J. K.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [28] Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study
    J. Magnant
    M. Ohresser
    Y. Allanore
    M. de Monte
    M. Lafosse-Marin
    D. Degenne
    J. L. Guilmot
    H. Watier
    E. Diot
    Rheumatology International, 2012, 32 : 2203 - 2207
  • [29] UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AT RISK FOR SYSTEMIC SCLEROSIS: PREDICTIVE ROLE OF ANTI-TOPOISOMERASE AND AVASCULAR AREAS
    Riccardi, A.
    Messiniti, V.
    Fasano, S.
    Valentini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1098 - 1098
  • [30] CONTINUOUS PRESENCE OF IGM ANTI-TOPOISOMERASE I ANTIBODIES INDICATES AN ONGOING IMMUNE RESPONSE IN SYSTEMIC SCLEROSIS
    Boonstra, M.
    Bakker, J. A.
    Grummels, A.
    Ninaber, M. K.
    Marsan, N. Ajmone
    Scherer, H. U.
    Toes, R. E.
    Huizinga, T. W.
    de Vries-Bouwstra, J. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 755 - 755
12345